Robert J. Hunkler

IQVIA (United States) — United States

Economics, Econometrics and Finance · Social Sciences

24h-index2.6kcitations35works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Economics and Policy(21), Health Systems, Economic Evaluations, Quality of Life(13), Antibiotic Use and Resistance(10), Pharmaceutical studies and practices(10), Biosimilars and Bioanalytical Methods(6)

Publications35 total

National trends in prescription drug expenditures and projections for 2020
American Journal of Health-System Pharmacy·2020· 58 citedOpen Access
National trends in prescription drug expenditures and projections for 2019
American Journal of Health-System Pharmacy·2019· 35 cited
National trends in prescription drug expenditures and projections for 2018
American Journal of Health-System Pharmacy·2018· 31 cited
Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015
Clinical Infectious Diseases·2017· 108 citedOpen Access
National trends in prescription drug expenditures and projections for 2017
American Journal of Health-System Pharmacy·2017· 58 cited
Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005–15
American Journal of Health-System Pharmacy·2017· 6 cited
Spending on Hepatitis C Antivirals in the United States, 2009–2015
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2016· 8 cited
Antibiotic prescriptions in the community by type of provider in the United States, 2005-2010
Journal of the American Pharmacists Association·2016· 48 cited
National trends in prescription drug expenditures and projections for 2016
American Journal of Health-System Pharmacy·2016· 100 cited
Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003–2012
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2015· 9 cited
Accuracy of annual prescription drug expenditure forecasts in<i>AJHP</i>
American Journal of Health-System Pharmacy·2015· 7 citedOpen Access
Spending on Hepatitis C Antivirals in the United States, 2008-2014
Value in Health·2015
National trends in prescription drug expenditures and projections for 2015
American Journal of Health-System Pharmacy·2015· 39 cited
US Outpatient Antibiotic Prescribing Variation According to Geography, Patient Population, and Provider Specialty in 2011
Clinical Infectious Diseases·2015· 555 citedOpen Access
Pharmacogenetics Implementation: Current Programs in Five US Medical
2015
Antibiotic Expenditures by Medication Class and Healthcare Setting in the United States, 2010–2013
Open Forum Infectious Diseases·2015· 8 citedOpen Access
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
The Annual Review of Pharmacology and Toxicology·2014· 502 citedOpen Access
Trends and Seasonal Variation in Outpatient Antibiotic Prescription Rates in the United States, 2006 to 2010
Antimicrobial Agents and Chemotherapy·2014· 164 citedOpen Access
National trends in prescription drug expenditures and projections for 2014
American Journal of Health-System Pharmacy·2014· 70 cited
Outpatient influenza antiviral prescription trends with influenza-like illness in the USA, 2008–2010
International Journal of Antimicrobial Agents·2013· 5 cited
page 1 of 2Next →

Frequent Co-authors

Glen T. Schumock(22), Katie J. Suda(20), Lee C. Vermeulen(20), Linda M. Matusiak(18), James M. Hoffman(17), Fred Doloresco(7), Nilay D. Shah(7), Karrie M. Hontz(7), Lauri A. Hicks(6), Edward C. Li(6), Michelle D. Wiest(6), JoAnn Stubbings(6), Nilay D. Shah(6), Rebecca M. Roberts(5), Thomas H. Taylor(4), Penny Grim(3), Henry M. Dunnenberger(2), Kristine R. Crews(2), Kelly E. Caudle(2), Ulrich Broeckel(2)